Cargando…

Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?

Detalles Bibliográficos
Autores principales:	Piccari, Lucilla, Bernardo, Roberto J., Rodríguez-Chiaradía, Diego, Vitulo, Patrizio, Wort, S. John, Sahay, Sandeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165840/ https://www.ncbi.nlm.nih.gov/pubmed/34104424 http://dx.doi.org/10.1177/20458940211018074

Ejemplares similares

The Effect of Borderline Pulmonary Hypertension on Survival in Chronic Lung Disease
por: Piccari, Lucilla, et al.
Publicado: (2022)

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative ‐ Group 3 Pulmonary Hypertension
por: Piccari, Lucilla, et al.
Publicado: (2023)

Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension
por: Nathan, Steven D., et al.
Publicado: (2022)

Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension
por: Nikkho, Sylvia M., et al.
Publicado: (2022)

Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease
por: Gillmeyer, Kari R., et al.
Publicado: (2021)

Effectiveness of pulmonary vasodilators on pulmonary hypertension associated with POEMS syndrome
por: Ohashi, Kana, et al.
Publicado: (2019)

Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension therapy in COVID-19
por: Franco, Veronica, et al.
Publicado: (2020)

Oxygen-Sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension
por: Morales-Cano, Daniel, et al.
Publicado: (2021)

Progression of pulmonary veno‐occlusive disease without pulmonary hypertension
por: Beshay, Sarah, et al.
Publicado: (2022)

Effects of Different Pulmonary Vasodilators on Arterial Saturation in a Model of Pulmonary Hypertension
por: Becker, Eva Maria, et al.
Publicado: (2013)

Improvement of pulmonary arterial compliance by pulmonary vasodilator in pulmonary hypertension from combined pulmonary fibrosis and emphysema
por: Kusaka, Kei, et al.
Publicado: (2019)

Pulmonary arterial hypertension due to pulmonary veno-occlusive disease in systemic sclerosis: Importance of early diagnosis and cautious use of pulmonary vasodilator therapy
por: Koito, Hitoshi
Publicado: (2012)

Effects of Exercise Training on Circulating Biomarkers of Endothelial Function in Pulmonary Arterial Hypertension
por: Rodríguez-Chiaradía, Diego A., et al.
Publicado: (2023)

Mechanisms of hypoxaemia in severe pulmonary hypertension associated with COPD
por: Piccari, Lucilla, et al.
Publicado: (2023)

Management of pulmonary vasodilator therapy in patients with pulmonary arterial hypertension during critical illness
por: Muzevich, Katie M, et al.
Publicado: (2014)

Pulmonary hypertension due to left heart disease
por: Vachiéry, Jean-Luc, et al.
Publicado: (2019)

Prescription Patterns for Pulmonary Vasodilators in the Treatment of Pulmonary Hypertension Associated With Chronic Lung Diseases: Insights From a Clinician Survey
por: Thomas, Christopher A., et al.
Publicado: (2021)

Adenosine as pulmonary vasodilator in ARDS
por: Molina, JM, et al.
Publicado: (1998)

Dramatic and sustained responsiveness of pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension to vasodilator therapy
por: May, Adam, et al.
Publicado: (2014)

Evaluation, Diagnosis, and Classification of Pulmonary Hypertension
por: Sarah, Beshay, et al.
Publicado: (2021)

Acute vasodilator testing: An opportunity to advance the precision care of pulmonary hypertension
por: Cirulis, Meghan M., et al.
Publicado: (2019)

Tumoral pulmonary hypertension
por: Price, Laura C., et al.
Publicado: (2019)

Pulmonary vasodilator use in continuous-flow left ventricular assist device management
por: Pirlamarla, Preethi, et al.
Publicado: (2021)

Controversies in pulmonary hypertension due to left heart disease
por: Cheli, Martino, et al.
Publicado: (2015)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to left heart disease
por: Alhabeeb, Waleed, et al.
Publicado: (2014)

Insights and Advances in the Diagnosis, Treatment, and Management of Pulmonary Hypertension
por: Guha, Ashrith, et al.
Publicado: (2021)

Pulmonary vasodilators can lead to various complications in pulmonary “arterial” hypertension associated with congenital heart disease
por: Chida-Nagai, Ayako, et al.
Publicado: (2020)

The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis
por: Shu, Tingting, et al.
Publicado: (2021)

Children with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension Treated with Pulmonary Vasodilators—The Pediatric Cardiologist Point of View
por: Migdał, Anna, et al.
Publicado: (2021)

Beneficial Effects of Pulmonary Vasodilators on Pre-Capillary Pulmonary Hypertension in Patients with Chronic Kidney Disease on Hemodialysis
por: Kimuro, Keiji, et al.
Publicado: (2022)

Pulmonary vasodilator therapy in sarcoidosis‐associated pulmonary hypertension may decrease lung function decline and mortality
por: Gayen, Shameek, et al.
Publicado: (2023)

Inhaled pulmonary vasodilators in refractory hypoxemia
por: Wright, Brian J.
Publicado: (2015)

Comparison of Balloon Pulmonary Angioplasty and Pulmonary Vasodilators for Inoperable Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Meta-Analysis
por: Kalra, Rajat, et al.
Publicado: (2020)

Pulmonary vasodilation in acute pulmonary embolism – a systematic review
por: Lyhne, Mads Dam, et al.
Publicado: (2020)

Erratum: Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: Pulmonary hypertension due to left heart disease
Publicado: (2017)

Machine learning to differentiate pulmonary hypertension due to left heart disease from pulmonary arterial hypertension
por: Swinnen, Katleen, et al.
Publicado: (2023)

Inhaled pulmonary vasodilators for persistent pulmonary hypertension of the newborn: safety issues relating to drug administration and delivery devices
por: Cosa, Nathan, et al.
Publicado: (2016)

An adult case of NOTCH3 mutation in pulmonary artery hypertension
por: Padhye, Akhilesh A., et al.
Publicado: (2022)

Definition and Management of Segmental Pulmonary Hypertension
por: Dimopoulos, Konstantinos, et al.
Publicado: (2018)

Updated definition of exercise pulmonary hypertension
por: Zeder, Katarina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2pra9djoo1iqkqto5dge1j128s